María González Cao

A Phase II Trial of the CD40 Agonist Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Disease Progression on Anti-PD-1.

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV).

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.

Lung cancer patients with COVID-19 in Spain: GRAVID study.

Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer.

Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients.

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.

SEOM clinical guideline for the management of cutaneous melanoma (2020).

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.